Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (18)

2020

  1. Aurora kinases in ovarian cancer

    ESMO Open, Vol. 5, Núm. 5

  2. Clinical relevance of +936 c>t vegfa and c.233c>t bfgf polymorphisms in chronic lymphocytic leukemia

    Genes, Vol. 11, Núm. 6, pp. 1-13

  3. MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

    Frontiers in Oncology, Vol. 10

2019

  1. A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

    Clinical Epigenetics, Vol. 11, Núm. 1

2017

  1. The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

    Scientific Reports, Vol. 7

2016

  1. The antitumor effect of metformin is mediated by miR-26a in breast cancer

    International Journal of Molecular Sciences, Vol. 17, Núm. 8

2015

  1. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer

    Journal of Cellular Biochemistry, Vol. 116, Núm. 9, pp. 2061-2073

2012

  1. Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling

    Menopause, Vol. 19, Núm. 3, pp. 319-327

2011

  1. Gene-gene interaction between CD40 and CD40L reduces bone mineral density and increases osteoporosis risk in women

    Osteoporosis International, Vol. 22, Núm. 5, pp. 1451-1458

  2. Wnt receptors, bone mass, and fractures: Gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication

    European Journal of Endocrinology, Vol. 164, Núm. 1, pp. 123-131

2010

  1. Alleles and haplotypes of the estrogen receptor alpha gene are associated with an increased risk of spontaneous abortion

    Fertility and Sterility, Vol. 93, Núm. 6, pp. 1809-1815

  2. Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women

    Journal of Bone and Mineral Metabolism, Vol. 28, Núm. 6, pp. 696-705

2009

  1. Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line

    Fertility and Sterility, Vol. 91, Núm. 4 SUPPL., pp. 1347-1350

  2. No effect of Cimicifuga racemosa extract on serum interleukin-6 levels and prostacyclin production by human endothelial cells

    European Journal of Obstetrics and Gynecology and Reproductive Biology

2008

  1. A C >t polymorphism located at position -1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women

    Osteoporosis International, Vol. 19, Núm. 8, pp. 1147-1152

  2. Comparative effects of 17β-estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice

    Osteoporosis International, Vol. 19, Núm. 6, pp. 793-800

  3. The Asn19Lys substitution in the osteoclast inhibitory lectin (OCIL) gene is associated with a reduction of bone mineral density in postmenopausal women

    Calcified Tissue International, Vol. 82, Núm. 5, pp. 348-353

2006

  1. Pérdida ósea posmenopáusica: Estudio del poliforfismo genético y efecto de la administración de fitoestrógenos sobre los marcadores de metabolismo óseo

    Patologia del Aparato Locomotor, Vol. 4, Núm. 4, pp. 271-280